Natasha van Eijkelenburg

10PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPacific Peoples youth and familySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 12, 2026
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Yvette A H Matser, André B P van Kuilenburg, Atia Samim

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Feb 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Yvette A H Matser, Atia Samim, Marta Fiocco

|Jan 08, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Lucas Moreno, Rebekah Weston, Cormac Owens

|Jun 10, 2022
Parental Sleep, Distress, and Quality of Life in Childhood Acute Lymphoblastic Leukemia: A Longitudinal Report from Diagnosis up to Three Years Later.

Niki Rensen, Lindsay Steur, Martha Grootenhuis

Pageof 2

Frequent Collaborators

3 joint publications

Karin P S Langenberg

3 joint publications

Guy Makin

3 joint publications

Pascal Chastagner

3 joint publications

Nadege Corradini